Acute Kidney Injury Therapeutics Market Size in the 7MM is expected to increase by 2034, estimated DelveInsight

DelveInsight's "Acute Kidney Injury Market Insights, Epidemiology and Market Forecast-2034" report delivers an in-depth understanding of the Acute Kidney Injury, historical and forecasted epidemiology as well as the Acute Kidney Injury market trends in the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan.

Discover Key Insights into the Acute Kidney Injury Market with DelveInsight's In-Depth Report @ Acute Kidney Injury Market Size- https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Acute Kidney Injury Market Report
• The total Mortality-adjusted Incident Cases of Acute Kidney Injury in the 7MM comprised 14.6 million cases in 2022 and are projected to increase during the forecast period.
• The total Mortality-adjusted Incident Cases of Acute Kidney Injury in the United States were approximately 5.7 in 2022.
• The US contributed to the largest incident population of Acute Kidney Injury, accounting for ~ 39% in the 7MM in 2022.
• Among EU4 and the UK, Germany accounted for the highest number of Acute Kidney Injury cases, followed by France, whereas Spain accounted for the lowest cases in 2022.
• The stage-specific cases of Acute Kidney Injury include Stage I, Stage II, and, Stage III. Out of which maximum cases were reported in stage I Acute Kidney Injury followed by stage II and Stage III.
• The leading Acute Kidney Injury Companies such as Alexion Pharmaceuticals, Alloksys Life Sciences, Am-pharma, Aptabio Therapeutics, Arch Biopartners, Guard Therapeutics, Novartis Pharmaceuticals, Ocelot Bio, Rediscovery Life Sciences, Renibus Therapeutics, River 2 Renal, and others.
• Promising Acute Kidney Injury Pipeline Therapies such as TIN816, SCD-F40, THR-184, ABT-719, QPI-1002, ASP1128, LSALT Peptide, and others.

Stay ahead in the Acute Kidney Injury Therapeutics Market with DelveInsight's Strategic Report @ Acute Kidney Injury Market Outlook- https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Kidney Injury Epidemiology Segmentation in the 7MM
• Total Acute Kidney Injury Incident Population in Hospitalized Patients
• Acute Kidney Injury Mortality Adjusted Incident Population
• Acute Kidney Injury Stage-specific Incident Population
• Acute Kidney Injury Age-specific Incident Population

Download the report to understand which factors are driving Acute Kidney Injury epidemiology trends @ Acute Kidney Injury Prevalence- https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Kidney Injury Emerging Drugs

• RBT-1: Renibus Therapeutics
RBT-1 by Renibus Therapeutics is an investigational drug that upregulates anti-inflammatory, antioxidant, and iron-scavenging pathways, activating a cytoprotective preconditioning response to reduce the risk of postoperative complications and improve patient outcomes following cardiothoracic surgery. The RBT-1-mediated pharmacologic preconditioning is thought to induce broad organ protection, thereby mitigating the risks of postoperative complications and improving both short- and long-term outcomes. In July 2023, Renibus Therapeutics announced that the US FDA granted Breakthrough Therapy Designation to RBT-1 for the reduction in risk of postoperative complications in patients undergoing cardiothoracic surgery and confirmed its alignment with the company's planned Phase III pivotal trial. In October 2023, Renibus Therapeutics announced that the first patient had been dosed in the pivotal Phase III PROTECT trial of RBT-1. Top-line results are expected in mid-2025. NDA filing is anticipated by early 2026.

• OCE-205: Ocelot Bio
Ocelot Bio's lead asset, OCE-205, is a therapeutic peptide with a differentiated mechanism of action that has the potential to improve outcomes for patients with complications of end-stage liver disease (ESLD). OCE-205's innovation emanates from its design as a mixed agonist-antagonist peptide selective for the vasopressin 1a (V1a) receptor with no vasopressin 2 (v2) receptor activity at drug concentrations well above those used in treating ESLD. In August 2022, Ocelot Bio announced that the US FDA granted ODD to OCE-205 for the treatment of hepatorenal syndrome. Ocelot Bio has completed the enrolment of patients in a Phase II clinical trial of OCE-205 in hepatorenal syndrome with acute kidney injury (HRS-Acute Kidney Injury).

Acute Kidney Injury Market Outlook
A robust pipeline with a novel mechanism of action and increasing incidence are major market drivers of the Acute Kidney Injury therapeutics market. Additionally, the Acute Kidney Injury pipeline is also expected to change the current dynamics of the market, which presently comprises biologics and molecules with new mechanisms of action. Currently, there are no targeted pharmacotherapies approved for the treatment of Acute Kidney Injury. At present, the therapeutic market size of Acute Kidney Injury is mainly dominated by the use of RRT and off-label drugs, which include various classes such as ACE inhibitors, ARBs, Diuretics, and NSAIDs. Various comorbidities like cardiovascular disease, hypertension, diabetes mellitus, pre-existing CKD, renal recovery, and others increase the risk of Acute Kidney Injury in these patients. As mentioned earlier, the current market of Acute Kidney Injury is majorly dependent on RRT and conventional therapies like NSAIDs, ACE inhibitors, ARBs, diuretics, etc.

Get In-Depth Knowledge on Acute Kidney Injury Market Trends and Forecasts with DelveInsight @ Acute Kidney Injury Treatment Market- https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Major Acute Kidney Injury Companies
The leading Acute Kidney Injury Companies such as Atox Bio, AM-Pharma Holding, Quark-Pharmaceuticals, LG Chem, Pharming Group, Angion Biomedica, Elysium Health, Sentien Biotechnologies, Pharmazz, Arch Biopartners, Guard Therapeutics, RegeneRx Biopharmaceuticals, Cerenis Therapeutics Alloksys, Vifor Pharma, and others.

Scope of the Acute Kidney Injury Market Research Report
• Coverage- 7MM
• Study Period- 2020-2034
• Acute Kidney Injury Companies- Alexion Pharmaceuticals, Alloksys Life Sciences, Am-pharma, Aptabio Therapeutics, Arch Biopartners, Guard Therapeutics, Novartis Pharmaceuticals, Ocelot Bio, Rediscovery Life Sciences, Renibus Therapeutics, River 2 Renal, and others.
• Acute Kidney Injury Pipeline Therapies- TIN816, SCD-F40, THR-184, ABT-719, QPI-1002, ASP1128, LSALT Peptide, and others.
• Acute Kidney Injury Market Dynamics: Acute Kidney Injury Market Drivers and Barriers
• Acute Kidney Injury Market Access and Reimbursement, Unmet Needs, KOL's Views, and Analyst's Views

Unlock Strategic Insights with DelveInsight's Comprehensive Acute Kidney Injury Market Report @ Acute Kidney Injury Market Drivers and Barriers- https://www.delveinsight.com/sample-request/acute-kidney-injury-aki-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. KEY INSIGHTS
2. REPORT INTRODUCTION
3. EXECUTIVE SUMMARY
4. KEY EVENTS
5. EPIDEMIOLOGY AND MARKET FORECAST METHODOLOGY
6. ACUTE KIDNEY INJURY MARKET OVERVIEW AT A GLANCE
7. DISEASE BACKGROUND AND OVERVIEW
8. TREATMENT AND PREVENTION
9. GUIDELINES
10. EPIDEMIOLOGY AND PATIENT POPULATION
11. PATIENT JOURNEY
12. EMERGING DRUGS
13. Acute Kidney Injury: THE 7MM ANALYSIS
14. KOL VIEWS
15. UNMET NEEDS
16. SWOT ANALYSIS
17. MARKET ACCESS AND REIMBURSEMENT
18. APPENDIX
19. DELVEINSIGHT CAPABILITIES
20. DISCLAIMER

List of the Top Selling Market Research Reports in 2025

Celiac Disease Market- https://www.delveinsight.com/report-store/celiac-disease-cd-market
Coronary Angioplasty Market- https://www.delveinsight.com/report-store/coronary-stents-market-market
CXCR Inhibitors Market- https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Overactive Bladder Syndrome Market- https://www.delveinsight.com/report-store/overactive-bladder-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Percutaneous Arterial Closure Device Market- https://www.delveinsight.com/report-store/vascular-closure-devices-market
Sglt2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Short Bowel Syndrome Drug Market- https://www.delveinsight.com/report-store/short-bowel-syndrome-market
Surgical Robotic System Market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical Sealant Market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Pouchitis Market- https://www.delveinsight.com/report-store/pouchitis-market
Radial Artery Compression Device Market- https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
Shingles Market - https://www.delveinsight.com/report-store/shingles-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-market
Catheter Stabilization Devices Market- https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
Orthopedic Splints Device Market- https://www.delveinsight.com/report-store/orthopedic-splints-market
Pediatric Neuroblastoma Market- https://www.delveinsight.com/report-store/neuroblastoma-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market-insight
Gene Therapy in CNS Disorder Market- https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/indwelling-catheters-market
CAR-T Pipeline- https://www.delveinsight.com/report-store/cart-cell-therapy-competitive-landscape
NK Cell Therapy Market- https://www.delveinsight.com/blog/nk-cell-therapy-in-cancer-treatment
Transcatheter Treatment Market- https://www.delveinsight.com/report-store/transcatheter-treatment-market
Phototherapies for Psoriasis Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Intraocular Lens Market - https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.